Morgan Stanley lowered Pfizer (NYSE:PFE) price target to $44
Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $45 to $44.
Morgan Stanley lowered Pfizer (NYSE:PFE) price target to $44 Read Post »